Baclofen and gamma-hydroxybutyrate withdrawal

Neurocritical Care

Volumn 8, Issue 3, 2008, Pages 430-433

  LeTourneau, Jennifer L ^a   Hagg, Daniel S ^a   Smith, Stephen M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Baclofen; Gamma hydroxybutyrate dependence; Intention tremor

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; ALPRAZOLAM; BACLOFEN; BENZODIAZEPINE; CONJUGATED ESTROGEN; ESCITALOPRAM; GABAPENTIN; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; LIOTHYRONINE; LISINOPRIL; LORAZEPAM; MEDROXYPROGESTERONE; METOCLOPRAMIDE; OXYCODONE; PAROXETINE; QUETIAPINE; WARFARIN; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; CENTRAL DEPRESSANT AGENT; OXYBATE SODIUM;

ADD ON THERAPY; ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CHRONIC FATIGUE SYNDROME; COMA; DEATH; DELIRIUM; DEPRESSION; DRUG DETOXIFICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FIBROMYALGIA; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INSOMNIA; MORNING DOSAGE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; TACHYCARDIA; TONIC CLONIC SEIZURE; TREATMENT FAILURE; TREMOR; WITHDRAWAL SYNDROME; CHEMICALLY INDUCED DISORDER; EPILEPSY; MIDDLE AGED;

ADJUVANTS, ANESTHESIA; BACLOFEN; BENZODIAZEPINES; DELIRIUM; EPILEPSY; FEMALE; GABA AGONISTS; HUMANS; MIDDLE AGED; SODIUM OXYBATE; SUBSTANCE WITHDRAWAL SYNDROME; TREMOR;

EID: 51449123237     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-008-9062-2     Document Type: Article

References (28)

1. CJ Teter SK. Guthrie 2001 A comprehensive review of MDMA, GHB: two common club drugs Pharmacotherapy 21 12 1486 513
2. O Miro S Nogue G Espinosa J To-Figueras M. Sanchez 2002 Trends in illicit drug emergencies: the emerging role of gamma-hydroxybutyrate J Toxicol Clin Toxicol 40 2 129 35
3. OC Snead III KM. Gibson 2005 Gamma-hydroxybutyric acid N Engl J Med 352 26 2721 32
4. DE Fuller CS. Hornfeldt 2003 From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy Pharmacotherapy 23 9 1205 9
5. The Xyrem International Study Group 2005 A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy J Clin Sleep Med 1 4 391 7
6. F Poldrugo G. Addolorato 1999 The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies Alcohol Alcohol 34 1 15 24
7. UCB and Jazz Pharmaceuticals Announce Expansion of Xyrem License to Include Fibromyalgia Syndrome (2006). http://www.jazzpharma.com/news.php?id=32.
8. G Addolorato E Castelli GF Stefanini G Casella F Caputo L Marsigli M Bernardi G. Gasbarrini 1996 An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group Alcohol Alcohol 31 4 341 5
9. TE Freese K Miotto CJ. Reback 2002 The effects and consequences of selected club drugs J Subst Abuse Treat 23 2 151 6
10. L Gallimberti MR Spella CA Soncini GL. Gessa 2000 Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence Alcohol 20 3 257 62
11. JE Dyer B Roth BA. Hyma 2001 Gamma-hydroxybutyrate withdrawal syndrome Ann Emerg Med 37 2 147 53
12. Project GHB (2002). http://www.projectghb.org/addiction/addiction.htm.
13. M McDonough N Kennedy A Glasper J. Bearn 2004 Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review Drug Alcohol Depend 75 1 3 9
14. OC Snead III CC. Liu 1993 GABAA receptor function in the gamma-hydroxybutyrate model of generalized absence seizures Neuropharmacology 32 4 401 9
15. AK Goodwin RR Griffiths PR Brown W Froestl C Jakobs KM Gibson EM. Weerts 2006 Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons Psychopharmacology (Berl) 189 1 71 82
16. Y Wu S Ali G Ahmadian CC Liu YT Wang KM Gibson AR Calver J Francis MN Pangalos O Carter Snead III. 2004 Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence Neuropharmacology 47 8 1146 56
17. N Gervasi Z Monnier P Vincent D Paupardin-Tritsch SW Hughes V Crunelli N. Leresche 2003 Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures J Neurosci 23 36 11469 78
18. V Hechler C Ratomponirina M. Maitre 1997 Gamma-hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide J Pharmacol Exp Ther 281 2 753 60
19. J Bormann OP Hamill B. Sakmann 1987 Mechanism of anion permeation through channels gated by glycine and gamma-aminobutyric acid in mouse cultured spinal neurones J Physiol 385 243 86
20. SM Smith R Zorec RN. McBurney 1989 Conductance states activated by glycine and GABA in rat cultured spinal neurones J Membr Biol 108 1 45 52
21. HG Cruz T Ivanova ML Lunn M Stoffel PA Slesinger C. Luscher 2004 Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system Nat Neurosci 7 2 153 9
22. K Kaupmann JF Cryan P Wellendorph C Mombereau G Sansig K Klebs M Schmutz W Froestl H van der Putten J Mosbacher 2003 Specific gamma-hydroxybutyrate- binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice Eur J Neurosci 18 10 2722 30
23. MA Smith SR Gergans MA. Lyle 2006 The motor-impairing effects of GABA(A) and GABA(B) agonists in gamma-hydroxybutyrate (GHB)-treated rats: cross-tolerance to baclofen but not flunitrazepam Eur J Pharmacol 552 1-3 83 9
24. E Perez J Chu T. Bania 2006 Seven days of gamma-hydroxybutyrate (GHB) use produces severe withdrawal Ann Emerg Med 48 2 219 20
25. G Chew A Fernando III. 2004 Epileptic seizure in GHB withdrawal Australas Psychiatry 12 4 410 11
26. LS Quang MC Desai JC Kraner MW Shannon AD Woolf TJ. Maher 2002 Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice Ann NY Acad Sci 965 461 72
27. ME Mullins SC. Fitzmaurice 2001 Lack of efficacy of benzodiazepines in treating gamma-hydroxybutyrate withdrawal J Emerg Med 20 4 418 20
28. MR Turner N. Gainsborough 2001 Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen J Psychopharmacol 15 1 61 3